Home
|
Site Map
|
Add to Favorites Link
|
Send page to a Friend
|
Contact us
About Us
Products
Research and Development
Publications and Press
Clinical Trials
Latest News
Contact us
Profile
Our mission
Partnerships
NGO and support groups
Contact Us
Medicines
Product licencing policy
Collaborate with us
Current projects
Future projects
A new model for pharmaceuticals
Scientific papers
In the news
Press release
Clinical reports
Projects
Perfil
Principios de Atuação
Parceiros e colaboradores
Organizações e grupos de apoio
Please wait..site under construction
Contate-nos
Medicamentos
Licenciamento de produtos
Colaborações e parcerias
Outros produtos e projetos em desenvolvimento
P-MAPA against visceral leishmaniaisis
Evaluation of the proteinaceous aggregate of ammonium and magnesium phospholinoleate-palmitoleate as an immunomodulator for treating visceral leismaniasis symptomatic dogs
P-MAPA and FDA -- Regulatory aspects
Farmabrasilis and Immunotherapeutica, the R&D partner, are preparing two applications for the immunomodulator P-MAPA to be submitted to Food and Drug Administration (FDA)
[
1
] [
2
] [
3
] [
4
] [
5
] [
6
] [
7
] [
8
] [
9
] [
10
] [
Next
] [
Last
]
Privacy Policy
|
Legal
|
[email protected]
all rights reserved